weight loss drugs

Reuters

Eli Lilly Sues 6 US Sellers Over Black-Market Retatrutide, Calls Products ‘Unverified’

BY Outlook Business Desk

novo nordisk

Novo Nordisk Sues Eli Lilly; Alleges Misleading Weight-Loss Drug Advertising

BY Outlook Business Desk

Representative Image : The GLP-1 Gold Rush Is Over

Why India's Generic Semaglutide Market Is Losing Momentum

BY Shristi Acharya

Weight-loss and diabetes drugs displayed at a pharmacy counter in India

Torrent Pharma Captures 38% of India’s Semaglutide Market

BY Outlook Business Desk

Nova Nordisks

Indian Pharma Lines Up for Ozempic-Like Weight-Loss Drugs

BY Outlook Business Desk

Suryansh Kumar, Founder and CEO of Elevate Now

Elevate Now Raises ₹18 Cr in Seed Funding to Scale India’s First Clinical Weight Loss Platform

BY Outlook Start-Up Desk

Sun Pharma Gets DCGI Nod For Generic Weight-Loss Drug Amid Patent Fight With Novo Nordisk

Sun Pharma Gets DCGI Nod For Generic Weight-Loss Drug

BY Outlook Business Desk

Advertisement

Shutterstock

Natco Challenges Novo Nordisk’s Semaglutide Patent

BY Outlook Business Desk

Legal experts say physicians are permitted to educate patients about weight-loss drugs, but not to advertise them.

Social Media ‘Doctors’ are Driving Indians to Weight-Loss Drugs Like Mounjaro, Wegovy. It’s Illegal

BY Yukta Mudgal

After Dr Reddy’s, Sun Pharma Gets Court Nod to Export Weight-Loss Drug

Sun Pharma Allowed to Export Semaglutide Like Dr Reddy's

BY Outlook Business Desk

Dr Reddys

Delhi HC Allows Dr Reddy’s to Export Weight-Loss Drug

BY Outlook Business Desk